Woojinntec Inc. (KOSDAQ:457550)
27,550
-600 (-2.13%)
At close: Apr 28, 2026
Woojinntec Revenue
In the year 2025, Woojinntec had annual revenue of 44.81B KRW with 1.93% growth. Woojinntec had revenue of 13.18B in the quarter ending December 31, 2025, with 17.82% growth.
Revenue
44.81B
Revenue Growth
+1.93%
P/S Ratio
5.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
256.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.81B | 848.63M | 1.93% |
| Dec 31, 2024 | 43.96B | 3.28B | 8.05% |
| Dec 31, 2023 | 40.68B | 3.32B | 8.88% |
| Dec 31, 2022 | 37.36B | 6.13B | 19.62% |
| Dec 31, 2021 | 31.24B | 4.91B | 18.63% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JETEMA, | 76.90B |
| IT-Chem CO.,Ltd | 61.97B |
| NOVAREX | 404.26B |
| DongWon Development | 387.34B |
| DAE HWA Pharmaceutical | 143.06B |
| TOVIS Co.,Ltd | 640.33B |
| Genexine | 5.81B |
| Asia Pacific Satellite | 47.81B |